Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI.

Wu LM, Chen XX, Xu JR, Zhang XF, Suo ST, Yao QY, Fan Y, Hu J.

Acad Radiol. 2013 Aug;20(8):939-46. doi: 10.1016/j.acra.2013.02.012. Epub 2013 Jun 5.

PMID:
23746384
2.

Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T.

Ohgiya Y, Suyama J, Sai S, Kawahara M, Takeyama N, Ohike N, Sasamori H, Munechika J, Saiki M, Onoda Y, Hirose M, Gokan T.

Magn Reson Med Sci. 2014;13(3):175-81. Epub 2014 Jul 2.

3.

Diffusion-weighted magnetic resonance imaging combined with T2-weighted images in the detection of small breast cancer: a single-center multi-observer study.

Wu LM, Chen J, Hu J, Gu HY, Xu JR, Hua J.

Acta Radiol. 2014 Feb;55(1):24-31. doi: 10.1177/0284185113492458. Epub 2013 Jul 22.

PMID:
23878358
4.

Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.

Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T, Suzuki K, Oshima H, Hara M, Shibamoto Y.

Radiology. 2009 Apr;251(1):112-21. doi: 10.1148/radiol.2511080873.

PMID:
19332849
5.

Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?

Watanabe H, Kanematsu M, Kondo H, Goshima S, Tsuge Y, Onozuka M, Moriyama N.

AJR Am J Roentgenol. 2009 May;192(5):1361-6. doi: 10.2214/AJR.08.1430.

PMID:
19380561
6.

T staging of rectal cancer: accuracy of diffusion-weighted imaging compared with T2-weighted imaging on 3.0 tesla MRI.

Feng Q, Yan YQ, Zhu J, Xu JR.

J Dig Dis. 2014 Apr;15(4):188-94. doi: 10.1111/1751-2980.12124.

PMID:
24373561
7.
8.

Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.

Lee M, Shin SJ, Oh YT, Jung DC, Cho NH, Choi YD, Park SY.

Eur Radiol. 2017 Sep;27(9):3752-3758. doi: 10.1007/s00330-017-4759-2. Epub 2017 Feb 6.

PMID:
28168374
9.

Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI.

Wang Y, Li Z, Meng X, Hu X, Shen Y, Morelli J, Lin H, Zhang Z, Hu D.

Medicine (Baltimore). 2016 Mar;95(10):e2951. doi: 10.1097/MD.0000000000002951.

10.

Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.

Ren J, Huan Y, Li F, Wang H, Ge Y, Chang Y, Yin H, Sun L.

J Magn Reson Imaging. 2009 Aug;30(2):351-6. doi: 10.1002/jmri.21727.

PMID:
19591203
11.

Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.

Lim HK, Kim JK, Kim KA, Cho KS.

Radiology. 2009 Jan;250(1):145-51. doi: 10.1148/radiol.2501080207. Epub 2008 Nov 18.

PMID:
19017927
12.

Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.

Chen M, Dang HD, Wang JY, Zhou C, Li SY, Wang WC, Zhao WF, Yang ZH, Zhong CY, Li GZ.

Acta Radiol. 2008 Jun;49(5):602-10. doi: 10.1080/02841850802004983.

PMID:
18568549
14.

Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.

Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, Trachtenberg J.

AJR Am J Roentgenol. 2007 Aug;189(2):323-8.

PMID:
17646457
15.

Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?

Vliegen RF, Beets GL, von Meyenfeldt MF, Kessels AG, Lemaire EE, van Engelshoven JM, Beets-Tan RG.

Radiology. 2005 Jan;234(1):179-88. Epub 2004 Nov 18.

PMID:
15550372
17.

Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer.

Yoshida S, Koga F, Kawakami S, Ishii C, Tanaka H, Numao N, Sakai Y, Saito K, Masuda H, Fujii Y, Kihara K.

Urology. 2010 Feb;75(2):387-91. doi: 10.1016/j.urology.2009.06.111. Epub 2009 Nov 14.

PMID:
19914691
18.

Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.

Kim CK, Park BK, Lee HM.

J Magn Reson Imaging. 2009 Feb;29(2):391-7. doi: 10.1002/jmri.21645.

PMID:
19161194
19.

The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis.

Wu LM, Xu JR, Ye YQ, Lu Q, Hu JN.

AJR Am J Roentgenol. 2012 Jul;199(1):103-10. doi: 10.2214/AJR.11.7634. Review.

PMID:
22733900
20.

Usefulness of diffusion-weighted imaging in the localization of prostate cancer.

Kajihara H, Hayashida Y, Murakami R, Katahira K, Nishimura R, Hamada Y, Kitani K, Kitaoka M, Suzuki Y, Kitajima M, Hirai T, Morishita S, Awai K, Yamashita Y.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):399-403. doi: 10.1016/j.ijrobp.2008.08.017. Epub 2008 Nov 18.

PMID:
19019564

Supplemental Content

Support Center